(S) -Sitagliptin CAS 823817-55-6

Khoom Qhia:

Cov Khoom Npe: (S) -Sitagliptin CAS TSIS TAU: 823817-55-6

Txhais:

(S) -3-amino-1- (3- (trifluoromethyl) -5,6-dihydro- [1,2,4] triazolo [4,3-a] pyrazin-7 (8H) -yl) -4- (2,4,5-trifluorophenyl) butan-1-ib;

Tshuaj& Cov Khoom Uas Lub Cev:

Zog: Cov hmoov dawb dawb

Ntsuas: ≥97.0%

Qhov ceev: 1.61g / cm3

Lub Ntsiab Kub: 529.9 ℃ ntawm 760 mmHg

Sitagliptin yog ib hom tshuaj tiv thaiv ntshav qab zib hom II uas tau pom zoo los ntawm FDA thiab thawj cov tshuaj dipeptidyl peptidase-IV inhibitor siv los kho hom mob ntshav qab zib hom II. Sitagliptin' s kev ua ntawm kev sib txawv yog txawv ntawm cov tshuaj tiv thaiv qhov ncauj hypoglycemic dhau los. Nws txhim kho kev muaj peev xwm ntawm cov neeg mob ntshav qab zib' tus kheej ntawm pancreatic islet β cov hlwb tsim cov tshuaj insulin thiab nce insulin ntau dua thaum cov ntshav qab zib nce siab, yog li tswj cov ntshav qabzib hauv cov neeg mob ntshav qab zib. Cov kev tshawb fawb soj ntsuam tau pom tias sitagliptin yog qhov ncauj siv tshuaj zoo nrog kev ua lag luam muaj txiaj ntsig zoo. Nws muaj cov nyhuv hypoglycemic tseem ceeb thaum siv nyob ib leeg lossis kev sib xyaw nrog metformin thiab pioglitazone, thiab muaj kev nyab xeeb rau, noj zoo, thiab muaj cov kev tsis zoo dua.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov hu rau peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.

Cim npe nrov: (s) -sitagliptin cas 823817-55-6, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

• Tug: (4S) -3 - [(5R) -5- (4-Fluorophenyl) -5-hydroxypentanoyl] -4-phenyl-1,3-oxazolidin-2-ib CAS 528565-93-7
• Tom ntej: (R) -Rivaroxaban CAS {{1}}